999 LOW-DOSE PEGINTERFERON ALFA-2A (40KD) (PEGASYS®) TO TREAT HEPATITIS C-INFECTED, END-STAGE RENAL DISEASE PATIENTS UNDERGOING HAEMODIALYSIS: FINAL STUDY RESULTS - Peck-Radosavljevic, M.; Boletis, J.; Besisik, F.; Ferraz, M. Lucia; Alric, L.; Samuel, D.; Messinger, D.; Cheinquer, H. (Journal of Hepatology, 2008)